Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

Signe Amalie Wolthers; Jakob Stenberg; Henning Bay Nielsen; Jakob Stensballe; Henrik Planck Pedersen

Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

Signe Amalie Wolthers, Jakob Stenberg, Henning Bay Nielsen, Jakob Stensballe, Henrik Planck Pedersen

Afdeling for Bedøvelse, Operation og TraumeCenter

2 Citationer (Scopus)

Abstract

The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.

Bidragets oversatte titel	Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	183
Udgave nummer	35
ISSN	0041-5782
Status	Udgivet - 30 aug. 2021

Emneord

COVID-19
COVID-19 Vaccines
Cerebral Hemorrhage
Humans
Male
SARS-CoV-2
Vaccination

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{0774720f33b74f589eb73288f8a7d1ba,

title = "Intracerebral h{\ae}moragi tolv dage efter vaccination med ChAdOx1 nCoV-19",

abstract = "The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.",

keywords = "COVID-19, COVID-19 Vaccines, Cerebral Hemorrhage, Humans, Male, SARS-CoV-2, Vaccination",

author = "Wolthers, {Signe Amalie} and Jakob Stenberg and Nielsen, {Henning Bay} and Jakob Stensballe and Pedersen, {Henrik Planck}",

year = "2021",

month = aug,

day = "30",

language = "Dansk",

volume = "183",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "35",

}

TY - JOUR

T1 - Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

AU - Wolthers, Signe Amalie

AU - Stenberg, Jakob

AU - Nielsen, Henning Bay

AU - Stensballe, Jakob

AU - Pedersen, Henrik Planck

PY - 2021/8/30

Y1 - 2021/8/30

N2 - The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.

AB - The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.

KW - COVID-19

KW - COVID-19 Vaccines

KW - Cerebral Hemorrhage

KW - Humans

KW - Male

KW - SARS-CoV-2

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85115452278&partnerID=8YFLogxK

M3 - Tidsskriftartikel

C2 - 34477089

SN - 0041-5782

VL - 183

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 35

ER -

Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

Abstract

Emneord

Andre filer og links

Fingeraftryk

Citationsformater